Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by P.R. Blank
Potential Health Economic Impact of Intravenous Iron Supplementation to Erythropoiesis-Stimulating Agent Treatment in Patients With Cancer- Or Chemotherapy-Induced Anemia
Oncology
Medicine
Cancer Research
Oncology
Related publications
PCN34 Cost Analysis of Anemia Treatment With Erythropoiesis-Stimulating Agents (ESAs) in Cancer Patients Receiving Chemotherapy in Italy
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Ferric Citrate Reduces Intravenous Iron and Erythropoiesis-Stimulating Agent Use in ESRD
Journal of the American Society of Nephrology : JASN
Medicine
Nephrology
Intravenous Iron Versus Oral Iron Versus No Iron With or Without Erythropoiesis- Stimulating Agents (ESA) for Cancer Patients With Anaemia: A Systematic Review and Network Meta-Analysis
Cochrane Database of Systematic Reviews
Anemia Treatment With Q2W Darbepoetin Alfa in Patients With Chronic Kidney Disease Naïve to Erythropoiesis-Stimulating Agents
Current Medical Research and Opinion
Medicine
Managing Chemotherapy Induced Anemia With Darbepoetin Alfa and Other Erythropoiesis Stimulating Agents: A Nurse's Perspective
Nursing: Research and Reviews
The Effect of Zinc Supplementation on Erythropoiesis-Stimulating Agent Hyporesponsive Anemia and Nutritional Status in a Zinc-Deficient Hemodialysis Patient
Nihon Toseki Igakkai Zasshi
Iron Deficient Erythropoiesis Might Play Key Role in Development of Anemia in Cancer Patients
Oncotarget
Oncology
Economic Evaluation of Intravenous Iron Treatments in the Management of Anemia Patients in Greece
ClinicoEconomics and Outcomes Research
Health Policy
Economics
Econometrics
Finance
Darbepoetin Alpha in the Treatment of Cancer Chemotherapy-Induced Anemia
Therapeutics and Clinical Risk Management
Chemical Health
Pharmacology
Safety
Medicine
Toxicology
Safety Research
Pharmaceutics
